Calendrier des promotions Boston Scientific
Calendrier avancé
Graphique simple
À propos de l'entreprise Boston Scientific
Компания Boston Scientific Corporation (NYSE: BSX) (аббревиатура BSC) (с 2008 года частично поглощенная компанией MAQUET) — один из производителей медицинского оборудования и расходных материалов для хирургии, включая сердечно-сосудистую хирургию, нейрохирургию, онкологию, эндоскопию, урологию, гинекологию и другие. Компания Boston Scientific известна как производитель стента Taxus, содержащего лекарственный препарат Паклитаксел, для открытия закупоренных артерий. Этот продукт был в центре судебного разбирательства о патентной защите. plus de détailsParamètres de base
IPO date
1992-05-18
ISIN
US1011371077
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 7.96 | 1 |
| P/BV | 6.06 | 1 |
| P/E | 71.91 | 1 |
Efficacité
| Nom | Signification | Grade |
| ROA | 4.97 | 1 |
| ROE | 9.03 | 3 |
| ROIC | 4.77 | 1 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 0 | 0 |
| DSI | 0 | 0 |
| Croissance moyenne du dividende | 0 | 0 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | 4.13 | 2 |
| Debt/Ratio | 0.2728 | 10 |
| Debt/Equity | 0.7904 | 9 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 68.99 | 8 |
| Rentabilité Ebitda, % | 42.24 | 6 |
| Rentabilité EPS, % | -1362.2 | 0 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 98.56 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| common.calendar.number_days.7d | 102.09 $ | 98.56 $ | 98.56 $ | -3.46 % | 0 % | 0 % |
| common.calendar.number_days.30d | 104.5 $ | 98.56 $ | 106.54 $ | -5.68 % | 0 % | 0 % |
| common.calendar.number_days.90d | 96.77 $ | 89.7 $ | 106.66 $ | 1.85 % | 0 % | 0 % |
| common.calendar.number_days.180d | 103.54 $ | 88.95 $ | 106.66 $ | -4.81 % | 0 % | 0 % |
| common.calendar.number_days.1y | 79.47 $ | 72.96 $ | 106.66 $ | 24.02 % | 0 % | 0 % |
| common.calendar.number_days.3y | 40.52 $ | 36 $ | 106.66 $ | 143.24 % | 0 % | 0 % |
| common.calendar.number_days.5y | 38.93 $ | 33.24 $ | 106.66 $ | 153.17 % | 0 % | 0 % |
| common.calendar.number_days.10y | 21.14 $ | 15.78 $ | 106.66 $ | 366.23 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 106.14 $ | 89.38 $ | 106.66 $ | -7.14 % | 0 % | 0 % |
Principaux propriétaires
Contenu dans l'ETF
ETF | Partager, % | Rentabilité pour l'année, % | Commission, % |
| BNY Mellon Sustainable US Equity ETF | 3.07 | 0 | 0.50 |
| Global X Longevity Thematic ETF | 2.55 | -2.24 | 0.50 |
| GraniteShares XOUT U.S. Large Cap ETF | 2.44387 | -25.71 | 0.60 |
| JPMorgan Social Advancement ETF | 2.44 | 0 | 0.49 |
| iShares Evolved U.S. Healthcare Staples ETF | 2.12 | 31.23 | 0.18 |
| BlackRock Future U.S. Themes ETF | 1.93927 | 40.94 | 0.60 |
| Fidelity Growth Opportunities ETF | 1.6752 | -7.91 | 0.38 |
| Invesco S&P 500® Equal Weight Health Care ETF | 1.65 | 815.08 | 0.40 |
| Fidelity New Millennium ETF | 1.33412 | -6.7 | 0.38 |
| IQ Engender Equality ETF | 1.31833 | 7.62 | 0.45 |
| Knowledge Leaders Developed World ETF | 1.27756 | -2.72 | 0.75 |
| iShares Morningstar Large-Cap Value ETF | 0.24926 | 53.47 | 0.25 |
| iShares Morningstar Large-Cap ETF | 0.24433 | 184.21 | 0.03 |
| iShares Morningstar Large-Cap Growth ETF | 0.24039 | 264.7 | 0.04 |
| Columbia U.S. ESG Equity Income ETF | 0.21299 | -3.6 | 0.35 |
| 1,52 | 89,89 | 0,39 |
|---|
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Mr. Michael F. Mahoney | Chairman, President & CEO | 4.83M | 1965 (60 années) |
| Mr. Daniel J. Brennan | Executive VP & CFO | 2.15M | 1966 (59 années) |
| Mr. Joseph M. Fitzgerald | Executive VP & Group President of Cardiology | 1.84M | 1964 (61 année) |
| Mr. Jonathan R Monson | Senior VP of Investor Relations | N/A | |
| Ms. Jodi Euerle Eddy | Senior VP and Chief Information & Digital Officer | N/A | 1974 (51 année) |
| Mr. John Bradley Sorenson | Executive Vice President of Global Operations | N/A | 1968 (57 années) |
| Mr. Arthur Crosswell Butcher | Executive VP and Group President of MedSurg & Asia Pacific | 1.49M | 1971 (54 année) |
| Ms. Emily Woodworth | Senior VP, Global Controller & Chief Accounting Officer | N/A | 1978 (47 années) |
| Mr. Jeffrey B. Mirviss M.B.A. | Executive VP & President of Peripheral Interventions | 1966 (59 années) | |
| Mr. Vance R. Brown | Senior VP, General Counsel & Corporate Secretary | 1970 (55 années) |
Informations sur l'entreprise
Adresse: United States, Marlborough, 300 Boston Scientific Way - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: http://www.bostonscientific.com
Site web: http://www.bostonscientific.com
